Published by Josh White on 16th July 2026
(Sharecast News) - Oxford Biomedica announced on Thursday that it has signed an agreement to provide process development and AAV GMP manufacturing services to Plowshare Therapies, supporting the biotechnology company's gene therapy programme for rare genetic diseases.
URL: http://www.digitallook.com/dl/news/story/36077036/...